YANG, G.,
SUN, J.,
SHI, H.,
ZHAO, S.,
GAREEV, I.,
BEYLERLI, O.,
PAVLOV, V.,
IZMAILOV, A. (2020) RNAs are of great interest as potential noninvasive
biomarkers for tumors, lipid disorders, diabetes mellitus
ZAGIDULLIN, N.SH.,
HAMITOVA, A.,
LAKMAN, I.,
KRIONI, I.,
GAREEVA, D.,
ZULKARNEEV, R.,
TULBAEV, E. (2020) The
biomarkes NT-proBNP, ST2 and Pentraxin-3 (Ptx-3) have emerged as potential powerful tools
and plasma. Circulating microRNA are potential
biomarkers for different expression profiles specific
Larionova, I.,
Tuguzbaeva, G.,
Ponomaryova, A.,
Stakheyeva, M.,
Cherdyntseva, N.,
V.N. Pavlov,
Choinzonov, E.,
Kzhyshkowska, J. (2020) progression: total amount of TAMs and specific phenotype of TAMs identified by functional
biomarkers. We
Длинные некодирующие РНК: какие перспективы? biomarkers and therapeutic targets for cancer. This review summarizes current knowledge about the biology
ZAGIDULLIN, N.SH.,
MOTLOCH, LUKAS J,,
GAREEVA, D.F.,
HAMITOVA, AYSILU,
LAKMAN, I.A.,
KRIONI, ILJA,
POPOV, DENIS,
ZULKARNEEV, R.KH.,
PAAR, VERA,
KOPP, KRISTEN,
JIRAK, PETER,
ISHMETOV, V.SH.,
HOPPE, UTA C.,
TULBAEV, EDUARD,
V.N. Pavlov (2020) worldwide. In addition to the classic
biomarker NT-proBNP, new
biomarkers like ST2 and Pentraxin-3 (Ptx-3
GAREEV, I.,
YANG, G.,
SUN, J.,
BEYLERLI, O.,
CHEN, X.,
ZHANG, D.,
ZHAO, B.,
ZHANG, R.,
SUN, Z.,
YANG, Q.,
LI, L.,
ZHAO, S.,
PAVLOV, V.,
SAFIN, S. (2020) that has been associated with high rates of mortality and morbidity. It is urgent to find new
biomarkers